Kirk Julienne K, D'Agostino Ralph B, Bell Ronny A, Passmore Leah V, Bonds Denise E, Karter Andrew J, Narayan K M Venkat
Family and Community Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1084, USA.
Diabetes Care. 2006 Sep;29(9):2130-6. doi: 10.2337/dc05-1973.
Among individuals with diabetes, a comparison of HbA(1c) (A1C) levels between African Americans and non-Hispanic whites was evaluated. Data sources included PubMed, Web of Science, the Cumulative Index to Nursing and Allied Health, the Cochrane Library, the Combined Health Information Database, and the Education Resources Information Center.
We executed a search for articles published between 1993 and 2005. Data on sample size, age, sex, A1C, geographical location, and study design were extracted. Cross-sectional data and baseline data from clinical trials and cohort studies for African Americans and non-Hispanic whites with diabetes were included. Diabetic subjects aged <18 years and those with pre-diabetes or gestational diabetes were excluded. We conducted a meta-analysis to estimate the difference in the mean values of A1C for African Americans and non-Hispanic whites.
A total of 391 studies were reviewed, of which 78 contained A1C data. Eleven had data on A1C for African Americans and non-Hispanic whites and met selection criteria. A meta-analysis revealed the standard effect to be 0.31 (95% CI 0.39-0.25). This standard effect correlates to an A1C difference between groups of approximately 0.65%, indicating a higher A1C across studies for African Americans. Grouping studies by study type (cross-sectional or cohort), method of data collection for A1C (chart review or blood draw), and insurance status (managed care or nonmanaged care) showed similar results.
The higher A1C observed in this meta-analysis among African Americans compared with non-Hispanic whites may contribute to disparity in diabetes morbidity and mortality in this population.
在糖尿病患者中,评估非裔美国人和非西班牙裔白人之间糖化血红蛋白(HbA1c,A1C)水平的差异。数据来源包括PubMed、科学网、护理及相关健康累积索引、Cochrane图书馆、联合健康信息数据库和教育资源信息中心。
我们检索了1993年至2005年间发表的文章。提取了样本量、年龄、性别、A1C、地理位置和研究设计的数据。纳入了非裔美国人和非西班牙裔白人糖尿病患者的横断面数据以及临床试验和队列研究的基线数据。排除了年龄小于18岁的糖尿病患者以及患有糖尿病前期或妊娠期糖尿病的患者。我们进行了荟萃分析,以估计非裔美国人和非西班牙裔白人A1C平均值的差异。
共审查了391项研究,其中78项包含A1C数据。11项研究有非裔美国人和非西班牙裔白人的A1C数据并符合入选标准。荟萃分析显示标准效应为0.31(95%置信区间0.39 - 0.25)。该标准效应对应两组之间A1C差异约为0.65%,表明在各项研究中,非裔美国人的A1C水平更高。按研究类型(横断面或队列)、A1C数据收集方法(病历审查或采血)和保险状况(管理式医疗或非管理式医疗)对研究进行分组,结果相似。
在这项荟萃分析中观察到,与非西班牙裔白人相比,非裔美国人的A1C水平更高,这可能导致该人群糖尿病发病率和死亡率的差异。